These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 17238855

  • 1. Monitoring human cytomegalovirus (HCMV) in HCMV-seropositive orthotopic liver-transplant recipients by means of quantitative real-time polymerase chain reaction.
    Mengelle C, Abravanel-Legrand F, Kamar N, Alain S, Basse G, Pillet A, Lavayssière L, Suc B, Izopet J, Rostaing L.
    Exp Clin Transplant; 2006 Dec; 4(2):537-43. PubMed ID: 17238855
    [Abstract] [Full Text] [Related]

  • 2. Monitoring HCMV infection with quantitative real-time PCR in HCMV-positive orthotopic liver transplant recipients, and predictive factors for treatment of the first episode of HCMV viremia.
    Pillet A, Mengelle C, Basse G, Ribes D, Kamar N, Muscari F, Lavayssière L, Suc B, Esposito L, Peron JM, Rostaing L.
    Transplant Proc; 2006 Sep; 38(7):2335-8. PubMed ID: 16980083
    [Abstract] [Full Text] [Related]

  • 3. Follow-up of 28 HCMV seropositive renal-transplant recipients: comparison of clinical, biological and virological parameters in the groups of treated versus untreated infected patients.
    Kamar N, Mengelle C, Yahyaoui S, Sandres-Sauné K, Durand D, Izopet J, Rostaing L.
    J Clin Virol; 2005 May; 33(1):35-42. PubMed ID: 15797363
    [Abstract] [Full Text] [Related]

  • 4. HHV-6-DNAemia related to CMV-DNAemia after liver transplantation.
    Härmä M, Loginov R, Piiparinen H, Halme L, Höckerstedt K, Lautenschlager I.
    Transplant Proc; 2005 Mar; 37(2):1230-2. PubMed ID: 15848678
    [Abstract] [Full Text] [Related]

  • 5. Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients.
    Lilleri D, Baldanti F, Gatti M, Rovida F, Dossena L, De Grazia S, Torsellini M, Gerna G.
    J Med Virol; 2004 Jul; 73(3):412-8. PubMed ID: 15170637
    [Abstract] [Full Text] [Related]

  • 6. Use of polymerase chain reaction to provide prognostic information on human cytomegalovirus disease after liver transplantation.
    Lao WC, Lee D, Burroughs AK, Lanzani G, Rolles K, Emery VC, Griffiths PD.
    J Med Virol; 1997 Mar; 51(3):152-8. PubMed ID: 9139077
    [Abstract] [Full Text] [Related]

  • 7. Simultaneous monitoring by real-time polymerase chain reaction of epstein-barr virus, human cytomegalovirus, and human herpesvirus-6 in juvenile and adult liver transplant recipients.
    Ono Y, Ito Y, Kaneko K, Shibata-Watanabe Y, Tainaka T, Sumida W, Nakamura T, Kamei H, Kiuchi T, Ando H, Kimura H.
    Transplant Proc; 2008 Dec; 40(10):3578-82. PubMed ID: 19100443
    [Abstract] [Full Text] [Related]

  • 8. Predictive factors for cytomegalovirus infection after orthotopic liver transplantation using an ultrasensitive polymerase chain reaction assay.
    Basse G, Esposito L, Mengelle C, Kamar N, Ribes D, Lavayssière L, Pillet A, Suc B, Barange K, Rostaing L.
    Transplant Proc; 2006 Sep; 38(7):2339-41. PubMed ID: 16980084
    [Abstract] [Full Text] [Related]

  • 9. Surveillance of cytomegalovirus (CMV) DNAemia in pediatric allogeneic stem cell transplantation: incidence and outcome of CMV infection and disease.
    Bordon V, Bravo S, Van Renterghem L, de Moerloose B, Benoit Y, Laureys G, Dhooge C.
    Transpl Infect Dis; 2008 Feb; 10(1):19-23. PubMed ID: 17511814
    [Abstract] [Full Text] [Related]

  • 10. Bronchiolitis obliterans syndrome and early human cytomegalovirus DNAaemia dynamics after lung transplantation.
    Westall GP, Michaelides A, Williams TJ, Snell GI, Kotsimbos TC.
    Transplantation; 2003 Jun 27; 75(12):2064-8. PubMed ID: 12829913
    [Abstract] [Full Text] [Related]

  • 11. Relationship between IgM antibody to human cytomegalovirus, virus load, donor and recipient serostatus, and administration of methylprednisolone as risk factors for cytomegalovirus disease after liver transplantation.
    Emery VC, Cope AV, Sabin CA, Burroughs AK, Rolles K, Lazzarotto T, Landini MP, Brojanac S, Wise J, Maine GT.
    J Infect Dis; 2000 Dec 27; 182(6):1610-5. PubMed ID: 11069231
    [Abstract] [Full Text] [Related]

  • 12. Clinical usefulness of human cytomegalovirus antigenemia assay after kidney transplantation.
    Kim CK, Song JH, Kim SM, Peck KR, Oh W, Huh W, Kim YG, Kim SJ, Joh JW, Lee NY, Park CG, Hwang ES, Cha CY, Oh HY.
    Transplantation; 2003 Jun 27; 75(12):2151-5. PubMed ID: 12829929
    [Abstract] [Full Text] [Related]

  • 13. Predictive factors for cytomegalovirus reactivation in cytomegalovirus-seropositive kidney-transplant patients.
    Kamar N, Mengelle C, Esposito L, Guitard J, Mehrenberger M, Lavayssière L, Ribes D, Cointault O, Durand D, Izopet J, Rostaing L.
    J Med Virol; 2008 Jun 27; 80(6):1012-7. PubMed ID: 18428146
    [Abstract] [Full Text] [Related]

  • 14. Comparison of antigenemia assay and semiquantitative polymerase chain reaction test for monitoring active cytomegalovirus infection in allogeneic hematopoietic cell transplant recipients.
    Pajand O, Ziyaeyan M, Mousavi S, Fatolahzadeh B, Hojabri Z, Bahador A, Abdossamadi Z.
    Exp Clin Transplant; 2008 Jun 27; 6(2):149-54. PubMed ID: 18816243
    [Abstract] [Full Text] [Related]

  • 15. Quantitative analysis of HCMV DNA load in whole blood of renal transplant patients using real-time PCR assay.
    Gouarin S, Vabret A, Gault E, Petitjean J, Regeasse A, Hurault de Ligny B, Freymuth F.
    J Clin Virol; 2004 Mar 27; 29(3):194-201. PubMed ID: 14962789
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of the COBAS Amplicor HCMV Monitor for early detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation.
    Lengerke C, Ljubicic T, Meisner C, Loeffler J, Sinzger C, Einsele H, Hebart H.
    Bone Marrow Transplant; 2006 Jul 27; 38(1):53-60. PubMed ID: 16788683
    [Abstract] [Full Text] [Related]

  • 17. A hybrid strategy for the prevention of cytomegalovirus-related complications in pediatric liver transplantation recipients.
    Madan RP, Campbell AL, Shust GF, Kahn AR, Wistinghausen B, Posada R, Kerkar N, Shneider BL, Emre S, Herold BC.
    Transplantation; 2009 May 15; 87(9):1318-24. PubMed ID: 19424031
    [Abstract] [Full Text] [Related]

  • 18. Diagnosis and monitoring of human cytomegalovirus infection in bone marrow transplant recipients by quantitative competitive PCR.
    Ziyaeyan M, Sabahi F, Alborzi A, Mahboudi F, Kazemnejad A, Ramzi M, Moravej A, Jaberi MM.
    Exp Clin Transplant; 2006 Jun 15; 4(1):470-4. PubMed ID: 16827646
    [Abstract] [Full Text] [Related]

  • 19. Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease.
    Manuel O, Asberg A, Pang X, Rollag H, Emery VC, Preiksaitis JK, Kumar D, Pescovitz MD, Bignamini AA, Hartmann A, Jardine AG, Humar A.
    Clin Infect Dis; 2009 Oct 15; 49(8):1160-6. PubMed ID: 19751151
    [Abstract] [Full Text] [Related]

  • 20. Detection and monitoring of human herpesvirus 7 in adult liver transplant patients: impact on clinical course and association with cytomegalovirus.
    Thomasini RL, Sampaio AM, Bonon SH, Boin IF, Leonardi LS, Leonardi M, Costa SC.
    Transplant Proc; 2007 Jun 15; 39(5):1537-9. PubMed ID: 17580183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.